Xenogeneic transplantation of erythropoietin-secreting cells immobilized in microcapsules using transient immunosuppression

Journal of Controlled Release

Volumn 137, Issue 3, 2009, Pages 174-178

  Murua, Ainhoa ^a,b   Orive, Gorka ^a,b   Hernández, Rosa M ^a,b   Pedraz, José Luis ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Alginate; Cell encapsulation; Erythropoietin; Tacrolimus; Xenotransplantation

Indexed keywords

CELL ENCAPSULATION; CELL ENCAPSULATIONS; CONTROLLED DELIVERY; ERYTHROPOIETIN; IMMUNOPROTECTION; MICROCAPSULES; MYOBLASTS; POLY-L-LYSINE; TACROLIMUS; THERAPEUTIC PROTEIN; XENOTRANSPLANTATION;

ALGINATE; AMINO ACIDS; DIELECTRIC DEVICES; RATS;

ENCAPSULATION;

ALGINATE POLYLYSINE ALGINATE; ERYTHROPOIETIN; TACROLIMUS;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FEMALE; IMMOBILIZED CELL; IMMUNOSUPPRESSIVE TREATMENT; MICROCAPSULE; MOUSE; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; XENOTRANSPLANTATION;

ALGINATES; ANIMALS; CAPSULES; ERYTHROPOIETIN; HEMATOCRIT; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MYOBLASTS; POLYLYSINE; RATS; RATS, INBRED F344; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS;

EID: 67649105754     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.04.009     Document Type: Article

References (39)

1. Löhr M., Hoffmeyer A., Kröger J., Freund M., Hain J., Holle A., Karle P., Knöfel W.T., Liebe S., Müller P., Nizze H., Renner M., Saller R.M., Wagner T., Hauenstein K., Günzburg W.H., and Salmons B. Microencapsulated cell-mediated treatment of inoperable pancreatic carcinoma. Lancet 357 (2001) 1591-1592
2. Wollert K.C., and Drexler H. Cell-based therapy for heart failure. Curr. Opin. Cardiol. 21 (2006) 234-239
3. Wilson J.T., and Chaikof E.L. Challenges and emerging technologies in the immunoisolation of cells and tissues. Adv. Drug Deliv. Rev. 60 (2008) 124-145
4. Calafiore R., Basta G., Luca G., Lemmi A., Montanucci M.P., Calabrese G., Racanicchi L., Mancuso F., and Brunetti P. Microencapsulated pancreatic islet allografts into nonimmunosuppressed patients with type 1 diabetes: first two cases. Diabetes Care 29 (2006) 137-138
5. Murua A., Portero A., Orive G., Hernández R.M., de Castro M., and Pedraz J.L. Cell microencapsulation technology: towards clinical application. J. Control. Release 132 (2008) 76-83
6. Sajadi A., Bensadoun J.-C., Schneider B.L., Lo Bianco C., and Aebischer P. Transient striatal delivery of GDNF via encapsulated cells leads to sustained behavioural improvement in a bilateral model of Parkinson disease. Neurobiol. Dis. 22 (2006) 119-129
7. Hao S., Su L., Guo X., Moyana T., and Xiang J. A novel approach to tumor suppression using microencapsulated engineered J558/TNF-alpha cells. Exp. Oncol. 27 (2005) 56-60
8. Jeon Y., Kwak K., Kim S., Kim Y., Lim J., and Baek W. Intrathecal implants of microencapsulated xenogeneic chromaffin cells provide a long-term source of analgesic substances. Transplant. Proc. 38 (2006) 3061-3065
9. Algire G.H., Weaver J.M., and Prehn R.T. Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J. Natl. Cancer Inst. 15 (1954) 493-507
10. Gray D.W. An overview of the immune system with specific reference to membrane encapsulation and islet transplantation. Ann. N. Y. Acad. Sci. 944 (2001) 226-239
11. Rayat G.R., and Gill R.G. Pancreatic islet xenotransplantation: barriers and prospects. Curr. Diab. Rep. 3 (2003) 336-343
12. Chang T.M.S. Semipermeable microcapsules. Science 146 (1964) 524-525
13. Lim F., and Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science 210 (1980) 908-910
14. Orive G., Hernández R.M., Gascón A.R., Calafiore R., Chang T.M., de Vos P., Hortelano G., Hunkeler D., Lacík I., Shapiro A.M., and Pedraz J.L. Cell encapsulation: promise and progress. Nat. Med. 9 (2003) 104-107
15. Orive G., Gascón A.R., Hernández R.M., Domínguez-Gil A., and Pedraz J.L. Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol. Sci. 25 (2004) 382-387
16. Aebischer P., Schluep M., Déglon N., Joseph J.M., Hirt L., Heyd B., Goddard M., Hammang J.P., Zurn A.D., Kato A.C., Regli F., and Baetge E.E. Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nat. Med. 2 (1996) 696-699
17. Paek J., Campaner A.B., Kim J.L., Golden L., Aaron R.K., Ciombor D.M., Morgan J.R., and Lysaght M.J. Microencapsulated cells genetically modified to overexpress human transforming growth factor-b1: viability and functionality in allogeneic and xenogeneic implant models. Tissue Eng. 12 (2006) 1733-1739
18. Dufrane D., van Steenberghe M., Goebbels R.-M., Saliez A., Guiot Y., and Gianello P. The influence of implantation site on the biocompatibility and survival of alginate encapsulated pig islets in rats. Biomaterials 27 (2006) 3201-3208
19. Zhang H., Zhu S.-J., Wang W., Wei Y.-J., and Hu S.-S. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function. Gene Ther. 15 (2008) 40-48
20. Vranken I., de Visscher G., Lebacq A., Verbeken E., and Flameng W. The recruitment of primitive Lin- Sca-1+, CD34+, c-kit+ and CD271+ cells during the early intraperitoneal foreign body reaction. Biomaterials 29 (2008) 797-808
21. Anderson J.M., Rodriguez A., and Chang D.T. Foreign body reaction to biomaterials. Semin. Immunol. 20 (2008) 86-100
22. Figliuzzi M., Plati T., Cornolti R., Adobati F., Fagiani A., Rossi L., Remuzzi G., and Remuzzi A. Biocompatibility and function of microencapsulated pancreatic islets. Acta Biomater. 2 (2006) 221-227
23. Orive G., de Castro M., Ponce S., Hernández R.M., Gascón A.R., Bosch M., Alberch J., and Pedraz J.L. Long-term expression of erythropoietin from myoblasts immobilized in biocompatible and neovascularized microcapsules. Mol. Ther. 12 (2005) 283-289
24. Ponce S., Orive G., Hernández R.M., Gascón A.R., Canals J.M., Muñoz M.T., and Pedraz J.L. In vivo evaluation of EPO-secreting cells immobilized in different alginate-PLL microcapsules. J. Control. Release 116 (2006) 28-34
25. Murua A., de Castro M., Orive G., Hernández R.M., and Pedraz J.L. In vitro characterization and in vivo functionality of erythropoietin-secreting cells immobilized in alginate-poly-L-lysine-alginate microcapsules. Biomacromolecules 8 (2007) 3302-3307
26. Schneider B.L., Peduto G., and Aebischer P. A self-immunomodulating myoblast cell line for erythropoietin delivery. Gene Ther. 8 (2001) 58-66
27. Peduto G., Rinsch C., Schneider B.L., Rolland E., and Aebischer P. Long-term host unresponsiveness to encapsulated xenogeneic myoblasts after transient immunosuppression. Transplantation 70 (2000) 78-85
28. Thevenot P., Hu W., and Tang L. Surface chemistry influences implant biocompatibility. Curr. Top Med. Chem. 8 (2008) 270-280
29. Ponce S., Orive G., Hernández R.M., Gascón A.R., Pedraz J.L., de Haan B.J., Faas M.M., Mathieu H.J., and de Vos P. Chemistry and the biological response against immunoisolating alginate-polycation capsules of different composition. Biomaterials 27 (2006) 4831-4839
30. Elliott R.B., Escobar L., Tan P.L., Garkavenko O., Calafiore R., Basta P., Vasconcellos A.V., Emerich D.F., Thanos C., and Bambra C. Intraperitoneal alginate-encapsulated neonatal porcine islets in a placebo-controlled study with 16 diabetic cynomolgus primates. Transplant. Proc. 37 (2005) 3505-3508
31. Dufrane D., Goebbels R.M., Saliez A., Guiot Y., and Gianello P. Six-month survival of microencapsulated pig islets and alginate biocompatibility in primates: proof of concept. Transplantation 81 (2006) 1345-1353
32. Grandoso L., Ponce S., Manuel I., Arrúe A., Ruiz-Ortega J.A., Ulibarri I., Orive G., Hernández R.M., Rodríguez A., Rodríguez-Puertas R., Zumárraga M., Linazasoro G., Pedraz J.L., and Ugedo L. Long-term survival of encapsulated GDNF secreting cells implanted within the striatum of parkinsonized rats. Int. J. Pharm. 343 (2007) 69-78
33. Yasuhara T., and Date I. Intracerebral transplantation of genetically engineered cells for Parkinson's Disease: toward clinical application. Cell Transplant. 16 (2007) 125-132
34. Zinkernagel R.M., and Hengartner H. Regulation of the immune response by antigen. Science 293 (2001) 251-253
35. Ribatti D., Conconi M.T., and Nussdorfer G.G. Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol. Rev. 59 (2007) 185-205
36. Müller-Ehmsen J., Schmidt A., Krausgrill B., Schwinger R.H., and Bloch W. Role of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthood. Am. J. Physiol. Heart Circ. Physiol. 290 (2006) H331-H340
37. Benelli R., Lorusso G., Albini A., and Noonan D.M. Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr. Pharm. Des. 12 (2006) 3101-3015
38. de Groot M., Schuurs T.A., and van Schilfgaarde R. Causes of limited survival of microencapsulated pancreatic islet grafts. J. Surg. Res. 121 (2004) 141-150
39. de Vos P., Faas M.M., Strand B., and Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27 (2006) 5603-5617